ACM
ASMB icon

Aquatic Capital Management’s Assembly Biosciences ASMB Stock Holding History

Aquatic Capital Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-220
Closed -$6.11K – 1252
2026
Q1 		$6.11K Buy
+220
New +$6.28K ﹤0.01% 1284

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Aquatic Capital Management's ASMB Position: Q2 2026 in Review

Aquatic Capital Management sold out of Assembly Biosciences (ASMB) in Q2 2026, closing a stake of 220 shares — an estimated $6.11K sold.

Aquatic Capital Management first reported a position in ASMB in Q1 2026 and held it in 1 quarter. The position peaked at $6.11K in Q1 2026. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Aquatic Capital Management reported no remaining Assembly Biosciences position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 220 Assembly Biosciences shares in Q2 2026, an estimated $6.11K.
  • Aquatic Capital Management first reported a position in Assembly Biosciences in Q1 2026 and held it in 1 quarter.
  • Aquatic Capital Management's Assembly Biosciences position peaked at $6.11K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.